NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
10.57
Dollar change
+0.06
Percentage change
0.57
%
IndexRUT P/E- EPS (ttm)-1.96 Insider Own38.59% Shs Outstand44.45M Perf Week0.38%
Market Cap470.98M Forward P/E- EPS next Y-2.21 Insider Trans7.61% Shs Float27.37M Perf Month7.20%
Enterprise Value160.01M PEG- EPS next Q0.93 Inst Own69.74% Short Float13.76% Perf Quarter73.28%
Income-79.11M P/S480.60 EPS this Y112.13% Inst Trans6.14% Short Ratio3.51 Perf Half Y-59.19%
Sales0.98M P/B1.17 EPS next Y-350.88% ROA-24.45% Short Interest3.77M Perf YTD-53.84%
Book/sh9.01 P/C1.40 EPS next 5Y25.50% ROE-27.05% 52W High28.99 -63.54% Perf Year-
Cash/sh7.54 P/FCF- EPS past 3/5Y-56.62% - ROIC-18.69% 52W Low4.17 153.48% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin-51.69% Volatility5.33% 6.37% Perf 5Y-
Dividend TTM- EV/Sales163.28 EPS Y/Y TTM- Oper. Margin-9339.10% ATR (14)0.66 Perf 10Y-
Dividend Ex-Date- Quick Ratio32.19 Sales Y/Y TTM- Profit Margin-8097.03% RSI (14)59.61 Recom1.40
Dividend Gr. 3/5Y- - Current Ratio32.19 EPS Q/Q-53.23% SMA201.87% Beta- Target Price24.25
Payout- Debt/Eq0.06 Sales Q/Q-30.91% SMA5019.15% Rel Volume0.29 Prev Close10.51
Employees75 LT Debt/Eq0.06 EarningsMay 15 AMC SMA200-22.23% Avg Volume1.07M Price10.57
IPOOct 25, 2024 Option/ShortYes / Yes EPS/Sales Surpr.-9.50% 119.00% Trades Volume316,591 Change0.57%
Date Action Analyst Rating Change Price Target Change
Jun-23-25Initiated H.C. Wainwright Buy $26
Feb-18-25Downgrade Wells Fargo Overweight → Equal Weight $14
Nov-19-24Initiated Wells Fargo Overweight $43
Nov-19-24Initiated TD Cowen Buy
Nov-19-24Initiated JP Morgan Overweight $38
Nov-19-24Initiated Cantor Fitzgerald Overweight $50
May-29-25 08:00AM
May-23-25 07:45AM
May-21-25 09:55AM
May-15-25 04:01PM
10:00AM
08:46AM Loading…
08:46AM
07:45AM
01:45AM
May-14-25 04:06PM
02:22PM
01:29PM
10:28AM
09:35AM
09:32AM
09:32AM
07:03AM Loading…
07:03AM
Apr-16-25 09:55AM
Mar-31-25 02:34PM
Mar-27-25 08:00AM
Mar-14-25 11:26AM
Mar-05-25 06:59PM
Feb-26-25 08:00AM
Feb-18-25 08:00AM
Feb-14-25 06:45AM
Feb-06-25 07:48AM
Jan-06-25 07:00AM
Dec-18-24 08:00AM
Nov-21-24 11:12PM
Nov-20-24 07:00AM
05:10AM
04:41PM Loading…
Oct-30-24 04:41PM
Oct-24-24 09:47PM
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finer JeffreyCEO and PresidentApr 02 '25Option Exercise2.7650,000138,000821,907Apr 04 04:13 PM
Finer JeffreyCEO and PresidentApr 03 '25Option Exercise2.765,00013,800826,907Apr 04 04:13 PM
Ezekowitz AlanDirectorMar 07 '25Buy6.9313,31992,270117,420Mar 10 04:18 PM
Ezekowitz AlanDirectorMar 06 '25Buy6.0041,355248,130104,101Mar 06 09:02 PM
Ezekowitz AlanDirectorMar 05 '25Buy5.8237,835220,26062,746Mar 06 09:02 PM
Ezekowitz AlanDirectorMar 04 '25Buy6.357,49147,54424,911Mar 06 09:02 PM
Finer JeffreyCEO and PresidentFeb 25 '25Buy5.6810,00056,765764,907Feb 27 06:53 PM
Finer JeffreyCEO and PresidentFeb 26 '25Buy5.704,00022,796768,907Feb 27 06:53 PM
Finer JeffreyCEO and PresidentFeb 27 '25Buy5.803,00017,400771,907Feb 27 06:53 PM
Labrucherie Gil MChief Financial OfficerFeb 25 '25Buy5.596,28235,11636,282Feb 27 06:51 PM
Labrucherie Gil MChief Financial OfficerFeb 27 '25Buy5.853,71821,75040,000Feb 27 06:51 PM
Third Rock Ventures VI, L.P.10% OwnerFeb 24 '25Buy6.0018,861113,1474,211,659Feb 26 04:15 PM
Third Rock Ventures VI, L.P.10% OwnerFeb 20 '25Buy5.92612,6743,627,0303,765,130Feb 24 04:15 PM
Third Rock Ventures VI, L.P.10% OwnerFeb 21 '25Buy5.94427,6682,540,3484,192,798Feb 24 04:15 PM
Labrucherie Gil MChief Financial OfficerFeb 20 '25Buy5.8814,50085,23425,000Feb 21 06:06 PM
Labrucherie Gil MChief Financial OfficerFeb 19 '25Buy5.5110,50057,81310,500Feb 21 06:06 PM
Labrucherie Gil MChief Financial OfficerFeb 21 '25Buy5.855,00029,25030,000Feb 21 06:06 PM
RA CAPITAL MANAGEMENT, L.P.DirectorOct 28 '24Buy18.004,170,00075,060,0005,523,915Oct 30 06:12 PM
Third Rock Ventures V, L.P.10% OwnerOct 28 '24Buy18.00370,5006,669,0006,215,591Oct 28 04:53 PM
Third Rock Ventures V, L.P.10% OwnerOct 28 '24Buy18.00279,5005,031,0003,152,456Oct 28 04:53 PM